Results 171 to 180 of about 15,432 (235)

The hormonal profile in women using combined monophasic oral contraceptive pills varies across the pill cycle: a temporal analysis of serum endogenous and exogenous hormones using liquid chromatography with tandem mass spectroscopy.

Am J Physiol Endocrinol Metab
Rodriguez LA, Casey E, Crossley E, Williams N, Dhaher YY.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The Risks of Oral Contraceptive Pills

Seminars in Reproductive Medicine, 2001
Oral contraceptive pills have been associated with increased risk for myocardial infarction, stroke, and venous thromboembolism. Studies have been published recently that suggest that these risks are minimal in appropriately chosen low-risk women. Stroke is a very uncommon event in childbearing women, occurring in approximately 11 per 100,000 women ...
H C, Pymar, M D, Creinin
openaire   +2 more sources

Risks and benefits of oral contraceptive pills

Best Practice & Research Clinical Obstetrics & Gynaecology, 2002
In the more than 40 years since the combined oral contraceptive pill was first marketed, much information has been obtained as to its risks. Considerably less publicity has been given to the balancing benefits that have also emerged. There has been an increasing realization that the risks are focused in those women with recognised risk factors, meaning
Rachel E, D'Souza, John, Guillebaud
openaire   +2 more sources

Estrogen potency of oral contraceptive pills

American Journal of Obstetrics and Gynecology, 1975
The estrogen potencies of 9 oral contraceptive pills, Enovid-E, Enovid-5, Ovulen, Demulen, Norinyl+80, Norinyl+50, Ovral, Norlestrin 1 mg. and Norlestrin 2.5 mg., were determined by bioassay. Relative estrogen potency was determined by analysis of variance.
H J, Chihal, R D, Peppler, R P, Dickey
openaire   +2 more sources

Oral Contraceptive Pills and Clinical Otosclerosis

International Journal of Gynecology & Obstetrics, 1978
ABSTRACTClinical otosclerosis is a familial disease which is more frequent among women in their reproductive years. The condition usually is aggravated by pregnancy. Endocrinologic variables may influence the time of onset and the course of the disease. It is suspected that oral contraceptives (OCs) might stimulate the onset of the disease. Six hundred
L, Podoshin, R, Gertner, M, Fradis, H, Feiglin, I, Eibschitz, M, Sharf, A, Reiter   +6 more
openaire   +2 more sources

Update on oral contraceptive pills and postcoital contraception

Current Opinion in Obstetrics and Gynecology, 1992
Modern oral contraceptive pills are safe for the majority of American women. The most important contraindications to oral contraceptive pill use are a history of thrombophlebitis or thromboembolism while on the pill or during pregnancy, smoking over 15 cigarettes daily if over 35 years of age, active liver disease, hypertension, diabetes, a lipid ...
openaire   +2 more sources